Cargando…
Revisiting endovascular treatment in below-the-knee disease. Are drug-eluting stents the best option?
Patients with below-the-knee arterial disease are primarily individuals suffering from critical limb ischemia (CLI), while a large percentage of these patients are also suffering from diabetes or chronic renal failure or both. Available data from randomized controlled trials and their meta-analysis...
Autores principales: | Spiliopoulos, Stavros, Kitrou, Panagiotis M, Brountzos, Elias N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259030/ https://www.ncbi.nlm.nih.gov/pubmed/30510636 http://dx.doi.org/10.4330/wjc.v10.i11.196 |
Ejemplares similares
-
Current evidence of drug-elution therapy for infrapopliteal arterial disease
por: Spiliopoulos, Stavros, et al.
Publicado: (2019) -
Overcoming ischemia in the diabetic foot: Minimally invasive treatment options
por: Spiliopoulos, Stavros, et al.
Publicado: (2021) -
Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
por: Katsanos, Konstantinos, et al.
Publicado: (2018) -
Response to Letter by Bonassi on Article, “Risk of Death Following Application of Paclitaxel‐Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials”
por: Katsanos, Konstantinos, et al.
Publicado: (2019) -
Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)